Cardiff Oncology CRDF
NASDAQ CRDF
$0.91 -0.02 (-2.15%)
At close: Oct 23, 2026 · 4:00 PM EDT

Cardiff Oncology (CRDF) Amortization of Deferred Charges (2014 - 2017)

Updated

Cardiff Oncology (CRDF) recorded Amortization of Deferred Charges of -$70,657 in Q2 2017, compared with -$66,689 a year earlier.

Analysis

Cardiff Oncology (CRDF) Amortization of Deferred Charges (2014 - 2017) Analysis & Trends

On a TTM basis, Cardiff Oncology's Amortization of Deferred Charges came in at -$271,124 as of Jun 30, 2017; for FY2016, it came in at -$201,037.

  • Per Business Quant, the preceding three quarters came in at -$66,119 (Q1 2017), -$67,659 (Q4 2016) and -$66,689 (Q3 2016).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn
10 Cardiff Oncology 62.34 Mn 27.84 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2017 45,557.00
Mar 31, 2017 68,223.00
Dec 31, 2016 68,093.00
Sep 30, 2016 172,399.00
Jun 30, 2016 -159,751.00
Mar 31, 2016 93,062.00
Dec 31, 2015 93,129.00
Sep 30, 2015 59,962.00
Jun 30, 2015 68,353.00
Mar 31, 2015 124,713.00
Dec 31, 2014 152,739.00
API Access

Cardiff Oncology Amortization of Deferred Charges API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=amortization-of-deferred-charges&ticker=CRDF&period=max&api_key=YOUR_API_KEY